Similarity Score |
Similarity Level |
Drug ID |
Developmental Stage |
0.8963 |
High Similarity |
NPD3027 |
Phase 3 |
0.8633 |
High Similarity |
NPD1613 |
Approved |
0.8633 |
High Similarity |
NPD1612 |
Clinical (unspecified phase) |
0.8535 |
High Similarity |
NPD7228 |
Approved |
0.8442 |
Intermediate Similarity |
NPD6234 |
Discontinued |
0.8406 |
Intermediate Similarity |
NPD1530 |
Clinical (unspecified phase) |
0.8403 |
Intermediate Similarity |
NPD7266 |
Discontinued |
0.8355 |
Intermediate Similarity |
NPD37 |
Approved |
0.8345 |
Intermediate Similarity |
NPD1529 |
Clinical (unspecified phase) |
0.8333 |
Intermediate Similarity |
NPD1653 |
Approved |
0.8312 |
Intermediate Similarity |
NPD4966 |
Approved |
0.8312 |
Intermediate Similarity |
NPD4965 |
Approved |
0.8312 |
Intermediate Similarity |
NPD4967 |
Phase 2 |
0.8288 |
Intermediate Similarity |
NPD6674 |
Discontinued |
0.8199 |
Intermediate Similarity |
NPD7074 |
Phase 3 |
0.8137 |
Intermediate Similarity |
NPD7054 |
Approved |
0.8086 |
Intermediate Similarity |
NPD7472 |
Approved |
0.7988 |
Intermediate Similarity |
NPD7240 |
Approved |
0.7971 |
Intermediate Similarity |
NPD3705 |
Approved |
0.7963 |
Intermediate Similarity |
NPD3818 |
Discontinued |
0.7958 |
Intermediate Similarity |
NPD4908 |
Phase 1 |
0.7879 |
Intermediate Similarity |
NPD7251 |
Discontinued |
0.7875 |
Intermediate Similarity |
NPD7199 |
Phase 2 |
0.7847 |
Intermediate Similarity |
NPD4907 |
Clinical (unspecified phase) |
0.7842 |
Intermediate Similarity |
NPD1610 |
Phase 2 |
0.7842 |
Intermediate Similarity |
NPD1091 |
Approved |
0.7831 |
Intermediate Similarity |
NPD7808 |
Phase 3 |
0.7818 |
Intermediate Similarity |
NPD6797 |
Phase 2 |
0.7771 |
Intermediate Similarity |
NPD1934 |
Approved |
0.774 |
Intermediate Similarity |
NPD3620 |
Phase 2 |
0.774 |
Intermediate Similarity |
NPD3619 |
Clinical (unspecified phase) |
0.7736 |
Intermediate Similarity |
NPD4868 |
Clinical (unspecified phase) |
0.773 |
Intermediate Similarity |
NPD2983 |
Phase 2 |
0.773 |
Intermediate Similarity |
NPD2982 |
Phase 2 |
0.7725 |
Intermediate Similarity |
NPD4338 |
Clinical (unspecified phase) |
0.7724 |
Intermediate Similarity |
NPD6410 |
Clinical (unspecified phase) |
0.7704 |
Intermediate Similarity |
NPD5283 |
Phase 1 |
0.7688 |
Intermediate Similarity |
NPD4381 |
Clinical (unspecified phase) |
0.7688 |
Intermediate Similarity |
NPD7975 |
Clinical (unspecified phase) |
0.7669 |
Intermediate Similarity |
NPD7184 |
Clinical (unspecified phase) |
0.7665 |
Intermediate Similarity |
NPD7685 |
Pre-registration |
0.766 |
Intermediate Similarity |
NPD2981 |
Phase 2 |
0.7639 |
Intermediate Similarity |
NPD3018 |
Phase 2 |
0.7639 |
Intermediate Similarity |
NPD2861 |
Phase 2 |
0.7626 |
Intermediate Similarity |
NPD1357 |
Approved |
0.7622 |
Intermediate Similarity |
NPD6166 |
Phase 2 |
0.7622 |
Intermediate Similarity |
NPD6168 |
Clinical (unspecified phase) |
0.7622 |
Intermediate Similarity |
NPD6167 |
Clinical (unspecified phase) |
0.7614 |
Intermediate Similarity |
NPD7237 |
Clinical (unspecified phase) |
0.761 |
Intermediate Similarity |
NPD2393 |
Clinical (unspecified phase) |
0.7606 |
Intermediate Similarity |
NPD4749 |
Approved |
0.7556 |
Intermediate Similarity |
NPD228 |
Approved |
0.7529 |
Intermediate Similarity |
NPD7090 |
Clinical (unspecified phase) |
0.7485 |
Intermediate Similarity |
NPD8055 |
Clinical (unspecified phase) |
0.7485 |
Intermediate Similarity |
NPD7804 |
Clinical (unspecified phase) |
0.7484 |
Intermediate Similarity |
NPD6143 |
Clinical (unspecified phase) |
0.7456 |
Intermediate Similarity |
NPD6559 |
Discontinued |
0.7452 |
Intermediate Similarity |
NPD6980 |
Clinical (unspecified phase) |
0.7448 |
Intermediate Similarity |
NPD6917 |
Clinical (unspecified phase) |
0.7444 |
Intermediate Similarity |
NPD7680 |
Approved |
0.7429 |
Intermediate Similarity |
NPD1548 |
Phase 1 |
0.7419 |
Intermediate Similarity |
NPD5058 |
Phase 3 |
0.7415 |
Intermediate Similarity |
NPD4625 |
Phase 3 |
0.7407 |
Intermediate Similarity |
NPD3021 |
Approved |
0.7407 |
Intermediate Similarity |
NPD3022 |
Approved |
0.7391 |
Intermediate Similarity |
NPD2801 |
Approved |
0.7391 |
Intermediate Similarity |
NPD2977 |
Approved |
0.7391 |
Intermediate Similarity |
NPD2978 |
Approved |
0.7391 |
Intermediate Similarity |
NPD8455 |
Phase 2 |
0.7361 |
Intermediate Similarity |
NPD4379 |
Clinical (unspecified phase) |
0.7358 |
Intermediate Similarity |
NPD4005 |
Discontinued |
0.7355 |
Intermediate Similarity |
NPD5307 |
Clinical (unspecified phase) |
0.7346 |
Intermediate Similarity |
NPD6374 |
Clinical (unspecified phase) |
0.7338 |
Intermediate Similarity |
NPD5698 |
Clinical (unspecified phase) |
0.7338 |
Intermediate Similarity |
NPD7157 |
Approved |
0.7312 |
Intermediate Similarity |
NPD4380 |
Phase 2 |
0.7303 |
Intermediate Similarity |
NPD4108 |
Discontinued |
0.7299 |
Intermediate Similarity |
NPD6843 |
Phase 3 |
0.7299 |
Intermediate Similarity |
NPD6841 |
Approved |
0.7299 |
Intermediate Similarity |
NPD6842 |
Approved |
0.7294 |
Intermediate Similarity |
NPD7993 |
Clinical (unspecified phase) |
0.7284 |
Intermediate Similarity |
NPD1465 |
Phase 2 |
0.7278 |
Intermediate Similarity |
NPD5844 |
Phase 1 |
0.7267 |
Intermediate Similarity |
NPD4060 |
Phase 1 |
0.7262 |
Intermediate Similarity |
NPD7473 |
Discontinued |
0.725 |
Intermediate Similarity |
NPD6055 |
Clinical (unspecified phase) |
0.7246 |
Intermediate Similarity |
NPD7843 |
Approved |
0.7244 |
Intermediate Similarity |
NPD6190 |
Approved |
0.7239 |
Intermediate Similarity |
NPD3817 |
Phase 2 |
0.7237 |
Intermediate Similarity |
NPD4536 |
Approved |
0.7237 |
Intermediate Similarity |
NPD4537 |
Clinical (unspecified phase) |
0.7237 |
Intermediate Similarity |
NPD4538 |
Approved |
0.7226 |
Intermediate Similarity |
NPD5177 |
Phase 3 |
0.7208 |
Intermediate Similarity |
NPD2029 |
Clinical (unspecified phase) |
0.7203 |
Intermediate Similarity |
NPD5125 |
Phase 3 |
0.7203 |
Intermediate Similarity |
NPD5126 |
Approved |
0.7197 |
Intermediate Similarity |
NPD7124 |
Phase 2 |
0.7195 |
Intermediate Similarity |
NPD3882 |
Suspended |
0.7186 |
Intermediate Similarity |
NPD6232 |
Discontinued |
0.7152 |
Intermediate Similarity |
NPD7075 |
Discontinued |
0.7152 |
Intermediate Similarity |
NPD1558 |
Phase 1 |
0.7152 |
Intermediate Similarity |
NPD1511 |
Approved |
0.7143 |
Intermediate Similarity |
NPD6099 |
Approved |
0.7143 |
Intermediate Similarity |
NPD6100 |
Approved |
0.7133 |
Intermediate Similarity |
NPD6859 |
Clinical (unspecified phase) |
0.7124 |
Intermediate Similarity |
NPD6111 |
Discontinued |
0.7124 |
Intermediate Similarity |
NPD7097 |
Phase 1 |
0.7115 |
Intermediate Similarity |
NPD1652 |
Phase 2 |
0.7115 |
Intermediate Similarity |
NPD3060 |
Approved |
0.7105 |
Intermediate Similarity |
NPD5124 |
Phase 1 |
0.7105 |
Intermediate Similarity |
NPD5123 |
Clinical (unspecified phase) |
0.7105 |
Intermediate Similarity |
NPD5735 |
Approved |
0.7105 |
Intermediate Similarity |
NPD230 |
Phase 1 |
0.7099 |
Intermediate Similarity |
NPD4678 |
Approved |
0.7099 |
Intermediate Similarity |
NPD4675 |
Approved |
0.7097 |
Intermediate Similarity |
NPD1375 |
Discontinued |
0.7097 |
Intermediate Similarity |
NPD3540 |
Phase 1 |
0.7083 |
Intermediate Similarity |
NPD3787 |
Discontinued |
0.708 |
Intermediate Similarity |
NPD2684 |
Approved |
0.7078 |
Intermediate Similarity |
NPD5588 |
Approved |
0.7078 |
Intermediate Similarity |
NPD5960 |
Phase 3 |
0.7075 |
Intermediate Similarity |
NPD8651 |
Approved |
0.707 |
Intermediate Similarity |
NPD6398 |
Clinical (unspecified phase) |
0.7067 |
Intermediate Similarity |
NPD7095 |
Approved |
0.7066 |
Intermediate Similarity |
NPD5494 |
Approved |
0.7063 |
Intermediate Similarity |
NPD1512 |
Approved |
0.7039 |
Intermediate Similarity |
NPD2238 |
Phase 2 |
0.7032 |
Intermediate Similarity |
NPD3539 |
Phase 1 |
0.703 |
Intermediate Similarity |
NPD8443 |
Clinical (unspecified phase) |
0.7013 |
Intermediate Similarity |
NPD4978 |
Clinical (unspecified phase) |
0.7012 |
Intermediate Similarity |
NPD7945 |
Clinical (unspecified phase) |
0.7012 |
Intermediate Similarity |
NPD3384 |
Approved |
0.7012 |
Intermediate Similarity |
NPD3383 |
Approved |
0.7012 |
Intermediate Similarity |
NPD3382 |
Approved |
0.7011 |
Intermediate Similarity |
NPD7549 |
Discontinued |
0.7007 |
Intermediate Similarity |
NPD3600 |
Clinical (unspecified phase) |
0.7006 |
Intermediate Similarity |
NPD4237 |
Approved |
0.7006 |
Intermediate Similarity |
NPD4236 |
Phase 3 |
0.7 |
Intermediate Similarity |
NPD7447 |
Phase 1 |
0.6993 |
Remote Similarity |
NPD6355 |
Discontinued |
0.6987 |
Remote Similarity |
NPD5762 |
Approved |
0.6987 |
Remote Similarity |
NPD5763 |
Approved |
0.6983 |
Remote Similarity |
NPD7879 |
Clinical (unspecified phase) |
0.6972 |
Remote Similarity |
NPD6671 |
Approved |
0.6971 |
Remote Similarity |
NPD8313 |
Approved |
0.6971 |
Remote Similarity |
NPD8312 |
Approved |
0.697 |
Remote Similarity |
NPD6818 |
Clinical (unspecified phase) |
0.697 |
Remote Similarity |
NPD7096 |
Clinical (unspecified phase) |
0.697 |
Remote Similarity |
NPD7819 |
Suspended |
0.6966 |
Remote Similarity |
NPD8397 |
Clinical (unspecified phase) |
0.6962 |
Remote Similarity |
NPD4628 |
Phase 3 |
0.6962 |
Remote Similarity |
NPD4109 |
Clinical (unspecified phase) |
0.6962 |
Remote Similarity |
NPD6331 |
Phase 2 |
0.6962 |
Remote Similarity |
NPD4110 |
Phase 3 |
0.6951 |
Remote Similarity |
NPD7615 |
Clinical (unspecified phase) |
0.6948 |
Remote Similarity |
NPD6653 |
Approved |
0.6937 |
Remote Similarity |
NPD7212 |
Phase 2 |
0.6937 |
Remote Similarity |
NPD4357 |
Discontinued |
0.6937 |
Remote Similarity |
NPD7213 |
Phase 3 |
0.6932 |
Remote Similarity |
NPD8053 |
Approved |
0.6932 |
Remote Similarity |
NPD8054 |
Approved |
0.6923 |
Remote Similarity |
NPD8127 |
Discontinued |
0.6919 |
Remote Similarity |
NPD3751 |
Discontinued |
0.6918 |
Remote Similarity |
NPD2219 |
Phase 1 |
0.6913 |
Remote Similarity |
NPD3094 |
Phase 2 |
0.6906 |
Remote Similarity |
NPD4750 |
Phase 3 |
0.6894 |
Remote Similarity |
NPD7004 |
Clinical (unspecified phase) |
0.6894 |
Remote Similarity |
NPD4160 |
Clinical (unspecified phase) |
0.6883 |
Remote Similarity |
NPD3657 |
Discovery |
0.6879 |
Remote Similarity |
NPD1550 |
Clinical (unspecified phase) |
0.6879 |
Remote Similarity |
NPD1552 |
Clinical (unspecified phase) |
0.6875 |
Remote Similarity |
NPD6783 |
Clinical (unspecified phase) |
0.6875 |
Remote Similarity |
NPD5536 |
Phase 2 |
0.6871 |
Remote Similarity |
NPD422 |
Phase 1 |
0.6867 |
Remote Similarity |
NPD6584 |
Phase 3 |
0.6863 |
Remote Similarity |
NPD6233 |
Phase 2 |
0.6859 |
Remote Similarity |
NPD6028 |
Clinical (unspecified phase) |
0.6859 |
Remote Similarity |
NPD6029 |
Clinical (unspecified phase) |
0.6855 |
Remote Similarity |
NPD3892 |
Phase 2 |
0.6852 |
Remote Similarity |
NPD7527 |
Clinical (unspecified phase) |
0.6852 |
Remote Similarity |
NPD1940 |
Clinical (unspecified phase) |
0.6852 |
Remote Similarity |
NPD52 |
Approved |
0.6852 |
Remote Similarity |
NPD7526 |
Approved |
0.6849 |
Remote Similarity |
NPD5846 |
Approved |
0.6849 |
Remote Similarity |
NPD6516 |
Phase 2 |
0.6835 |
Remote Similarity |
NPD970 |
Clinical (unspecified phase) |
0.6835 |
Remote Similarity |
NPD1549 |
Phase 2 |
0.6829 |
Remote Similarity |
NPD7261 |
Clinical (unspecified phase) |
0.6826 |
Remote Similarity |
NPD5353 |
Approved |
0.6826 |
Remote Similarity |
NPD5402 |
Approved |
0.6824 |
Remote Similarity |
NPD6959 |
Discontinued |
0.6818 |
Remote Similarity |
NPD4140 |
Approved |
0.6816 |
Remote Similarity |
NPD7906 |
Approved |
0.6815 |
Remote Similarity |
NPD1242 |
Phase 1 |
0.6813 |
Remote Similarity |
NPD2677 |
Approved |
0.6813 |
Remote Similarity |
NPD5241 |
Discontinued |
0.6807 |
Remote Similarity |
NPD6801 |
Discontinued |
0.6802 |
Remote Similarity |
NPD27 |
Approved |
0.6802 |
Remote Similarity |
NPD2489 |
Approved |
0.6797
|
Remote Similarity |
NPD5110 |
Phase 2 |